Sightera Biosciences

Sightera BiosciencesSightera Biosciences
SB

Sightera Biosciences

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

Website
2025ActiveAntwerp, Belgium
Rate
Advertise here

About

Sightera Biosciences is a biotechnology company focused on AI-driven drug discovery. It differentiates itself by training its AI models on proprietary data derived directly from patient-derived biological material, particularly from patients with advanced, therapy-resistant, or end-staged diseases. The company aims to accelerate the development of novel therapies by designing small molecules based on biological responses observed in patient-derived systems, rather than chemical properties alone.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Sightera Biosciences do?

Sightera Biosciences is a biotechnology company focused on AI-driven drug discovery. It differentiates itself by training its AI models on proprietary data derived directly from patient-derived biological material, particularly from patients with advanced, therapy-resistant, or end-staged diseases. The company aims to accelerate the development of novel therapies by designing small molecules based on biological responses observed in patient-derived systems, rather than chemical properties alone.

How much funding has Sightera Biosciences raised?

Sightera Biosciences has raised a total of $3M in funding. The most recent round on record is Pre-Seed.

Where is Sightera Biosciences headquartered?

Sightera Biosciences is headquartered in Antwerp, Belgium.

When was Sightera Biosciences founded?

Sightera Biosciences was founded in 2025.

What industry does Sightera Biosciences operate in?

Sightera Biosciences operates in Biotechnology, Artificial Intelligence, Drug Discovery, Oncology, Fibrosis, Biotech.

What is Sightera Biosciences's revenue?

StartupHub estimates Sightera Biosciences's annual revenue at $357K (range $98K to $1.1M, 36% confidence), based on comparable companies in the sector.

What is Sightera Biosciences's valuation?

StartupHub estimates Sightera Biosciences's effective valuation at $10.1M (range $7.5M to $18.0M, 25% confidence), based on comparable companies in the sector.